NCT05010603Recruiting
Late Onset Alzheimer's Disease
Source: ClinicalTrials.gov · Last updated 18 May 2026
Brief summary (registry, in English)
The goal of this study is to is to focus on the genetic influences on Alzheimer's Disease (AD) risk. The investigators are looking for families and/or individuals (affected or unaffected) of any ethic background (African American, Caucasian, and Hispanics) with a family history of AD and willing to participate.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 10000 (estimated)
- First submitted
- 11 Aug 2021
- Start date
- 15 Nov 2016
- Primary completion date
- 30 Apr 2027
- Lead sponsor
- Columbia University
- Diseases
- Alzheimer disease
- NCT number
- NCT05010603
What you commit to
- Study type: Observational
- Planned participants: 10000
- From 15 Nov 2016 to the primary completion date, 30 Apr 2027
- 12 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study design.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- failure to identify an appropriate informant;
- uncertainty of the clinical diagnosis of Alzheimer's disease or other related disorder;
- failure to identify a living sibling with AD or other related disorder (except in the cases of sporadic FTD and sporadic LBD);
Other
- discovery of additional diagnosis that could account for the clinical manifestations;
- unwillingness to participate;
- participants lacking the capacity to consent who do not have a surrogate or proxy or next of kin to provide consent.
Who the study is looking for
- Established diagnosis of definite or probable AD or have a diagnosis of a related neurodegenerative disorder such as Frontotemporal Dementia (FTD) or Lewy Body Dementia (LBD) (will also recruit sporadic FTD and LBD) cases.
- a living sibling with probable or possible AD;
- a third living relative affected with AD (onset age 50 or older) or unaffected (60 or older);
- participants in the proband's generation with an identified companion serving as an informant;
- participants who have capacity to consent or participants lacking capacity to consent with a surrogate/proxy in place to provide consent.
Age in the registry: 55 years to - · Sex: All · Accepts healthy volunteers
Sites (12)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Rush University Coordinator of this site? Confirm its status | Aurora | United States | Recruiting |
| Indiana University Coordinator of this site? Confirm its status | Bloomington | United States | Recruiting |
| University of Texas, Southwestern Coordinator of this site? Confirm its status | Dallas | United States | Recruiting |
| NCRAD at Indiana University Coordinator of this site? Confirm its status | Indianapolis | United States | Recruiting |
| University of Miami Coordinator of this site? Confirm its status | Miami | United States | Recruiting |
| Columbia University Irving Medical Center Coordinator of this site? Confirm its status | New York | United States | Recruiting |
| University of Pittsburgh Coordinator of this site? Confirm its status | Pittsburgh | United States | Recruiting |
| North Carolina State University Coordinator of this site? Confirm its status | Raleigh | United States | Recruiting |
| Mayo Clinic Coordinator of this site? Confirm its status | Rochester | United States | Recruiting |
| University of Washington Coordinator of this site? Confirm its status | Seattle | United States | Recruiting |
| Joanne Norton Coordinator of this site? Confirm its status | St Louis | United States | Recruiting |
| University of Washington Coordinator of this site? Confirm its status | Washington D.C. | United States | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.